Marketview360 Logo
ScreensWatchlistMarketsNewsAI AssistantPricing
⌘K
Marketview360 Logo

The fastest way to screen, analyze, and track US equities. Real-time data, powerful ratios, and clean design for the modern investor.

Product

  • Stock Screener
  • Market Overview
  • Market News
  • AI Assistance

Support

  • Help Center
  • Feedback
  • About
  • Blog
  • System Status

© 2026 Marketview360 Inc. All rights reserved.

PrivacyTermsCookiesDisclaimer
Home/
Screener/
BPMC.US
Blueprint Medicines Corp logo

Blueprint Medicines Corp

BPMC.US
NASDAQ•Healthcare
Low: $73.04High: $129.65
$129.46
52 Week Range
+0.14%
Market Close
Key Metrics
Peer Comparison
TickerNamePriceMkt CapP/E1D %
ABBV.USAbbVie Inc$410.36B97.92-0.81%
GILD.USGilead Sciences Inc$184.91B21.97-1.92%
BSX.USBoston Scientific Corp$114.04B39.61-1.43%
EXAS.USEXACT Sciences Corporation$19.73B0.00-0.68%
WST.USWest Pharmaceutical Services Inc$18.32B37.46-1.92%
MOH.USMolina Healthcare Inc$7.93B17.273.24%
MMED.USMiniMed Group, Inc. Common Stock$4.48B0.00-5.24%
AMRX.USAmneal Pharmaceuticals, Inc. Class A Common Stock$4.34B1381.00-1.74%
BCRX.USBioCryst Pharmaceuticals Inc$1.87B0.00-2.41%
NBTX.USNanobiotix$1.50B0.00-4.37%
Latest News

No recent news available for BPMC.US

See news for other symbols →
Company Profile

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic m…

Sector
Healthcare
Industry
Biotechnology
Employees
682
Founded
2015
Country
Not available
Website
https://www.blueprintmedicines.com
Analyst Ratings
Hold
Target: $130.29(+0.6%)
Based on 19 analysts
1
Strong Sell
0
Sell
15
Hold
1
Buy
2
Strong Buy